Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
Quarter 2025/FY
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Operating Revenue | €6.26B | €5.82B | €22.90B | €5.80B | €5.85B |
| Net Interest Income | €4.13B | €4.06B | €14.68B | €3.82B | €3.71B |
| -Interest Income | €20.94B | €4.06B | €51.05B | €3.82B | €3.71B |
| Non-Interest Income | €2.13B | €1.77B | €8.22B | €1.98B | €2.15B |
| -Fees and Commissions | €1.28B | €1.24B | €4.60B | €1.22B | €1.17B |
| -Other Non-Interest Income | -€388.00M | €526.00M | €70.00M | €744.00M | €918.00M |
| -Gain Loss on Sale of Assets | -€1.32B | €7.00M | -€3.81B | €15.00M | €66.00M |
| Credit Losses Provision | -€279.00M | -€346.00M | -€1.30B | -€365.00M | -€326.00M |
| Non-Interest Expense | €3.11B | €3.20B | €12.58B | €3.23B | €2.94B |
| Other Non-Interest Expenses | -€1.52B | €3.20B | €3.42B | €3.23B | €2.94B |
| Other Income (Expense) | €50.00M | -€25.00M | €132.00M | -€104.00M | -€29.00M |
| Special Income (Charges) | €50.00M | -€25.00M | -€77.00M | -€104.00M | -€29.00M |
| -Less:Restructuring and Mergern & Acquisition | -€50.00M | €25.00M | – | €104.00M | €73.00M |
| Pretax Profit | €2.92B | €2.26B | €9.15B | €2.10B | €2.56B |
| Tax | €902.00M | €652.00M | €2.55B | €606.00M | €703.00M |
| Net Profit | €2.02B | €1.61B | €6.60B | €1.49B | €1.86B |
| Profit from Continuing Operations | €2.02B | €1.61B | €6.60B | €1.49B | €1.86B |
| Minority Interests | €70.00M | €50.00M | €275.00M | €78.00M | €70.00M |
| Net Income to Parent Company | €1.95B | €1.56B | €6.33B | €1.41B | €1.79B |
| Net Income to Common Stockholders | €1.95B | €1.56B | €6.33B | €1.41B | €1.79B |
| Basic EPS | €0.68 | €0.54 | €2.12 | €0.48 | €0.60 |
| Diluted EPS | €0.68 | €0.54 | €2.12 | €0.48 | €0.60 |
| Dividend Per Share | €0.74 | €0.00 | €1.05 | €0.00 | €0.35 |
| -Interest Expense | – | – | €36.37B | – | – |
| -Dividend Income | – | – | €116.00M | – | – |
| -Trading Gain Loss | – | – | €5.06B | – | – |
| -Foreign Exchange Trading Gains | – | – | €2.18B | – | – |
| Professional Expense and Contract Services Expense | – | – | €440.00M | – | – |
| Selling and Admin Expenses | – | – | €8.04B | – | – |
| -Selling & Marketing Expense | – | – | €443.00M | – | – |
| -General & Admin Expense | – | – | €7.60B | – | – |
| Depreciation & Amortization & Depletion | – | – | €681.00M | – | – |
| -Depreciation & Amortization | – | – | €681.00M | – | – |
| Income from Associates & Other Participating Interests | – | – | €209.00M | – | – |
| -Less:Other Special Charges | – | – | €68.00M | – | – |
| -Less:Write Off | – | – | €9.00M | – | – |
| -Gain on Sale of Business | – | – | – | – | €44.00M |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €1.16T | €1.14T | €1.05T | €1.05T | €1.09T |
| Cash, Cash Equivalents & Federal Funds Sold | €64.95B | €68.59B | €59.73B | €59.73B | €82.87B |
| -Cash and Cash Equivalents | €64.95B | €68.59B | €52.89B | €52.89B | €82.87B |
| Securities Investment | €285.95B | €278.13B | €140.09B | €140.09B | €251.48B |
| -Trading Securities | €64.73B | €61.86B | €29.39B | €29.39B | €60.69B |
| -Available for Sale Securities | €161.81B | €156.94B | €57.28B | €57.28B | €138.91B |
| -Short Term Investments | €59.41B | €59.33B | €53.42B | €53.42B | €51.88B |
| Long Term Equity Investment | €1.18B | €1.52B | €1.61B | €1.61B | €1.55B |
| Derivative Assets | €1.50B | €1.98B | €26.00B | €26.00B | €1.60B |
| Net Loan | €789.56B | €772.52B | €813.66B | €813.66B | €740.71B |
| -Gross Loan | €795.58B | €778.51B | €819.58B | €819.58B | €746.54B |
| -Allowance for Loans and Lease Losses | €6.02B | €6.00B | €5.91B | €5.91B | €5.83B |
| Receivables | €408.00M | – | €938.00M | €938.00M | – |
| -Other Receivables | €408.00M | – | €938.00M | €938.00M | – |
| Net PPE | €2.65B | €2.59B | €2.48B | €2.48B | €2.43B |
| Goodwill and Other Intangible Assets | €1.74B | €1.55B | €1.51B | €1.51B | €1.46B |
| -Goodwill | €588.00M | – | €477.00M | €477.00M | – |
| -Other Intangible Assets | €1.15B | – | €1.04B | €1.04B | – |
| Deferred Assets | €908.00M | – | €893.00M | €893.00M | – |
| Other Assets | €11.90B | €10.46B | €5.96B | €5.96B | €10.05B |
| Total Liabilities | €1.11T | €1.09T | €1.00T | €1.00T | €1.04T |
| Total Deposits | €804.87B | €785.46B | €787.01B | €787.01B | €762.83B |
| Derivative Product Liabilities | €1.26B | €1.62B | €22.02B | €22.02B | €1.46B |
| Trading Liabilities | €102.06B | €99.82B | €2.55B | €2.55B | €91.69B |
| Payables | €517.00M | – | €3.27B | €3.27B | – |
| -Total Tax Payable | €517.00M | – | €1.25B | €1.25B | – |
| Long Term Debt and Capital Lease Obligation | €185.08B | €182.90B | €179.22B | €179.22B | €170.48B |
| -Long Term Debt | €185.08B | €182.90B | €178.17B | €178.17B | €170.48B |
| Non-Current Liabilities | €902.00M | – | €941.00M | €941.00M | – |
| Non-Current Deferred Liabilities | €363.00M | – | €380.00M | €380.00M | – |
| Other Liabilities | €14.33B | €15.66B | €7.08B | €7.08B | €15.34B |
| Total Equity | €51.39B | €52.06B | €50.95B | €50.95B | €50.57B |
| Stockholders' Equity | €50.25B | €50.87B | €49.70B | €49.70B | €49.45B |
| Capital Stock | €29.00M | – | €30.00M | €30.00M | – |
| -Common Stock | €29.00M | – | €30.00M | €30.00M | – |
| Additional Paid-In Capital | €17.12B | – | €17.12B | €17.12B | – |
| Retained Earnings | €35.16B | – | €35.63B | €35.63B | – |
| Less: Treasury Stock | €1.45B | – | €2.40B | €2.40B | – |
| Gains/Losses Not Affecting Retained Earnings | -€605.00M | – | -€674.00M | -€674.00M | – |
| Minority Interests | €1.14B | €1.19B | €1.26B | €1.26B | €1.12B |
| Assets Held for Sale | – | €164.00M | €164.00M | €164.00M | €205.00M |
| -Money Market Investments | – | – | €6.84B | €6.84B | – |
| -Gross PPE | – | – | €6.33B | €6.33B | – |
| -Accumulated Depreciation | – | – | -€3.85B | -€3.85B | – |
| Prepaid Assets | – | – | €829.00M | €829.00M | – |
| Foreclosed Assets | – | – | €17.00M | €17.00M | – |
| Defined Pension Benefit | – | – | €528.00M | €528.00M | – |
| -Other Payable | – | – | €2.02B | €2.02B | – |
| -Long Term Capital Lease Obligation | – | – | €1.05B | €1.05B | – |
| Employee Benefits | – | – | €981.00M | €981.00M | – |
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
2023 ANNUAL (EUR) |
2022 ANNUAL (EUR) |
2021 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€6.38B | -€22.54B | -€11.34B | -€11.11B | -€14.94B |
| Net cash flow from continuing operations | -€6.38B | -€22.55B | -€11.34B | -€11.11B | -€14.95B |
| Net Income from Continuing Operations | €9.15B | €9.30B | €10.49B | €5.50B | €6.78B |
| Gain/Loss from Continuing Operations | -€427.00M | €1.13B | €447.00M | – | – |
| Depreciation & Depletion & Amortization | €665.00M | €673.00M | €674.00M | €711.00M | €834.00M |
| Other Non-Cash Items | €3.44B | -€780.00M | -€2.84B | €5.53B | €415.00M |
| Change in Working Capital | -€18.14B | -€31.31B | -€17.94B | -€23.24B | -€21.62B |
| -Change in Loans | -€54.82B | -€42.14B | €6.88B | -€25.13B | -€27.60B |
| -Change in Other Current Assets | -€18.68B | €577.00M | -€5.42B | -€6.96B | -€370.00M |
| -Change in Other Current Liabilities | €11.53B | -€7.85B | €6.80B | €4.42B | -€6.50B |
| -Change in Other Working Capital | €55.36B | €10.25B | -€19.40B | €8.86B | €6.35B |
| Net cash flow from investing | -€15.70B | -€6.03B | -€8.55B | -€5.31B | €6.22B |
| Net Cash Flow from Continuing Investing Activities | -€15.70B | -€6.03B | -€8.55B | -€5.31B | €6.22B |
| Net PPE Purchase and Sale | -€312.00M | -€282.00M | -€189.00M | -€148.00M | -€145.00M |
| Net Investment Purchase and Sale | -€15.38B | -€5.75B | -€8.36B | -€5.17B | €6.34B |
| Net Other Investing Changes | -€1.00M | – | €1.00M | – | -€1.00M |
| Financing Cash Flow | €8.25B | €5.37B | €18.40B | €4.65B | €5.39B |
| Net Cash Flow from Continuing Financing Activities | €8.24B | €5.37B | €18.40B | €4.65B | €5.39B |
| Net Issuance Payments of Debt | €15.83B | €13.07B | €24.90B | €9.46B | €9.38B |
| Net Common Stock Issuance | -€3.71B | -€3.82B | -€3.53B | -€1.72B | -€1.61B |
| Cash Dividends Paid | -€3.88B | -€3.88B | -€2.97B | -€3.09B | -€2.38B |
| Net Other Financing Activities | €1.00M | €1.00M | – | -€1.00M | €1.00M |
| Ending Cash Balance | €54.15B | €69.07B | €93.01B | €95.39B | €107.67B |
| Net Change in Cash | -€13.83B | -€23.20B | -€1.48B | -€11.77B | -€3.34B |
| Beginning Cash Balance | €69.07B | €93.01B | €95.39B | €107.67B | €111.57B |
| Effect of Exchange Rate Changes | -€1.09B | -€740.00M | -€898.00M | -€504.00M | -€565.00M |
| Free Cash Flow | -€6.73B | -€22.88B | -€11.59B | -€11.34B | -€15.13B |
| Net Business Purchase and Sale | – | €0.00 | €0.00 | €7.00M | €27.00M |